De Ceunynck Radiotherapy (Public limited company)
De Ceunynck Radiotherapy is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0680.604.062. It was founded on 28-08-2017. Its registered office is in Aartselaar. Its main activity is: Manufacture of basic pharmaceutical products and pharmaceutical preparations. Its annual accounts for 2024 report equity of € -1 600 105 and a loss of € 400 468. These accounts report 2.5 full-time equivalents. Addrly gives it a financial health grade of E, on a scale from A (safest) to E (most at risk). Its annual accounts for the 2025 financial year have not been filed, although the legal deadline has passed.
Information last updated on 14-10-2026.
Company information
Key figures of De Ceunynck Radiotherapy
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € -400 468+72 % | € -1 433 148 | € 292 881-53 % | € 616 636 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € -1 600 105-33 % | € -1 199 637 | € 233 512 | € -59 370 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 635 020-19 % | € 780 005-65 % | € 2 239 262-66 % | € 6 673 813 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € 82 766 | € -155 483 | € 766 484-21 % | € 967 875 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | 2.5-29 % | 3.5-12 % | 4+186 % | 1.4 |
Financial estimate
- 1 Shareholders
Similar companies
Other companies in the same activity nearby.
| Company | Town |
|---|---|
| Janssen Pharmaceutica | 2340 Beerse |
| PFIZER MANUFACTURING BELGIUM | 2870 Puurs-Sint-Amands |
| Organon Heist | 2220 Heist-op-den-Berg |
| Kaneka Belgium | 2260 Westerlo |
| DE CEUSTER MESTSTOFFEN | 2280 Grobbendonk |
| CAPSUGEL BELGIUM | 2880 Bornem |
| MEDICA | 2550 Kontich |
| Novartis Manufacturing | 2870 Puurs-Sint-Amands |
Frequently asked questions
Is De Ceunynck Radiotherapy still active? Yes. The Crossroads Bank for Enterprises lists De Ceunynck Radiotherapy as active.
What is the VAT number of De Ceunynck Radiotherapy? The VAT number of De Ceunynck Radiotherapy is BE 0680.604.062.
When was De Ceunynck Radiotherapy founded? De Ceunynck Radiotherapy was founded on 28-08-2017.
What is the address of De Ceunynck Radiotherapy? The current registered office of De Ceunynck Radiotherapy is Kontichsesteenweg 36, 2630 Aartselaar.
When did De Ceunynck Radiotherapy last file annual accounts? The latest annual accounts of De Ceunynck Radiotherapy were filed on 29-08-2025.
Does De Ceunynck Radiotherapy file its annual accounts on time? The annual accounts of De Ceunynck Radiotherapy for the 2025 financial year have not been filed, although the legal deadline has passed.
How many employees does De Ceunynck Radiotherapy have? De Ceunynck Radiotherapy employs 2.5 full-time equivalents according to its most recent annual accounts.
Is De Ceunynck Radiotherapy financially healthy? Addrly gives De Ceunynck Radiotherapy a financial health grade of E, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is De Ceunynck Radiotherapy profitable? The annual accounts of De Ceunynck Radiotherapy for 2024 show a loss of € 400 468.
What is the equity of De Ceunynck Radiotherapy? The equity of De Ceunynck Radiotherapy was € -1 600 105 at the close of the 2024 financial year.
Who are the directors of De Ceunynck Radiotherapy? The annual accounts of De Ceunynck Radiotherapy record 3 mandates. The names, roles and dates are visible with a free account.
Can De Ceunynck Radiotherapy receive Peppol e-invoices? Yes. De Ceunynck Radiotherapy is registered on the Peppol network and can receive structured electronic invoices.
What does De Ceunynck Radiotherapy do? The main activity of De Ceunynck Radiotherapy is: Manufacture of basic pharmaceutical products and pharmaceutical preparations.